<DOC>
	<DOCNO>NCT00001056</DOCNO>
	<brief_summary>To determine safety immune response vaccinia-derived HIV-1 recombinant envelope glycoprotein ( gp160 ) dose 200 mcg human volunteer ; evaluate duration antibody response relationship dose frequency inoculation . Although recent advance make antiviral therapy AIDS , currently cure AIDS . It likely ultimate control disease depend development safe effective vaccine HIV .</brief_summary>
	<brief_title>A Phase I Multicenter Clinical Trial Evaluate Safety Immunogenicity Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein ( gp160 ) Human Immunodeficiency Virus : Evaluation 200-mcg Dose</brief_title>
	<detailed_description>Although recent advance make antiviral therapy AIDS , currently cure AIDS . It likely ultimate control disease depend development safe effective vaccine HIV . Healthy , adult volunteer without identifiable high-risk behavior HIV-1 infection randomly assign receive three injection either 200 mcg gp160 vaccine placebo . At participate site , four volunteer receive vaccine two volunteer receive placebo . Primary immunization two booster immunization day 30 day 180 do outpatient set . Volunteers closely monitor first 2 week postimmunization ( primary booster ) , extensively follow 2 year . Volunteers may offer additional booster preparation 12 month .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vaccinia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Inclusion Criteria Patients must : Normal , healthy , HIVnegative adult fully comprehend purpose detail study . Available 2 year followup . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : History positive PPD ( tuberculin test ) abnormal chest xray . Positive syphilis serology ( e.g. , RPR ) . Positive circulate hepatitis B surface antigen . Patients follow exclude : They sexual partner identifiable highrisk behavior HIV infection . History immunodeficiency chronic illness . Evidence psychological psychiatric problem may lead noncompliance . Prior Medication : Excluded : Immunosuppressive medication . Prior Treatment : Excluded : Blood transfusion cryoprecipitates within past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>Vaccinia Virus</keyword>
	<keyword>Viral Vaccines</keyword>
	<keyword>HIV-1</keyword>
	<keyword>HIV Envelope Protein gp160</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>